Impiricus provides an AI-powered engagement engine connecting pharmaceutical resources directly with healthcare professionals (HCPs) through real-time, ethical channels. This platform leverages extensive interaction data to facilitate targeted communication, ensuring physicians receive relevant information when needed. The result is accelerated patient access to new treatments while lowering go-to-market costs for life science organizations.
Funding
$4.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

FVFounders
Product
Problem
Traditional methods of engaging healthcare professionals (HCPs) are becoming less effective due to diminishing face-to-face interactions and information overload. Reaching and maintaining engagement with a broad network of HCPs is challenging for pharmaceutical and healthcare companies.
Solution
Impiricus provides a platform designed to directly connect healthcare professionals with relevant industry resources and information. The platform uses an API-centric approach to deliver high-value content to HCPs, bypassing traditional barriers and integrating into existing omnichannel strategies. By providing a direct channel for communication, Impiricus aims to improve engagement rates and provide a more efficient way for healthcare companies to reach their target audience. The platform facilitates compliant, pre-approved conversations and leverages NPI-level data to fuel Next Best Actions.
Target Audience
The primary target audience includes pharmaceutical companies, healthcare organizations, and other industry partners seeking to engage with healthcare professionals.
Features
- Proprietary network of over 800,000 HCPs
- API-centric platform for seamless integration with existing systems
- Custom URL tracking for campaign performance analysis
- HCP council for content review and curation
- NPI-level data for targeted messaging
- Compliant, pre-approved conversations